Company profilePharmaceutical#445 of 1,318 in Pakistan✓ No DRAP alerts

ROGEN PHARMACEUTICALS

Pharmaceutical company · 35 brands · 37 molecules

35 registered products 18 pharmaceutical brands 37 distinct molecules 0 DRAP alerts

Company overview

35
registered products
18
pharmaceutical brands
37
distinct molecules
0
therapeutic classes
0
DRAP alerts

ROGEN PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 35 product registrations across 37 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Fusidic Acid3 brands
Montelukast2 brands
Diclofenac2 brands
Cefixime2 brands
Tretinoin1 brand

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.19 shared molecules
SHROOQ PHARMACEUTICALS19 shared molecules
NEUTRO PHARMA (PVT) LTD.18 shared molecules
VALOR PHARMACEUTICALS17 shared molecules
AMBROSIA PHARMACEUTICALS16 shared molecules

Get the full profile for ROGEN

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.